Liza Chacko, Tushar Kotecha, Adam Ioannou, Niket Patel, Ana Martinez-Naharro, Yousuf Razvi, Rishi Patel, Paolo Massa, Lucia Venneri, James Brown, Aldostefano Porcari, Kristopher Knott, Charlotte Manisty, Daniel Knight, Tim Lockie, Roby Rakhit, Helen Lachmann, Ashutosh Wechelakar, Carol Whelan, Markella Ponticos, James Moon, Arantxa González, Janet Gilbertson, Mattia Riefolo, Ornella Leone, Hui Xue, Philip Hawkins, Peter Kellman, Julian Gillmore, Marianna Fontana
AIMS: Cardiac involvement is the main driver of clinical outcomes in systemic amyloidosis and preliminary studies support the hypothesis that myocardial ischaemia contributes to cellular damage. The aims of this study were to assess the presence and mechanisms of myocardial ischaemia using cardiovascular magnetic resonance (CMR) with multiparametric mapping and histopathological assessment. METHODS AND RESULTS: Ninety-three patients with cardiac amyloidosis (CA) (light-chain amyloidosis n = 42, transthyretin amyloidosis n = 51) and 97 without CA (three-vessel coronary disease [3VD] n = 47, unobstructed coronary arteries n = 26, healthy volunteers [HV] n = 24) underwent quantitative stress perfusion CMR with myocardial blood flow (MBF) mapping...
January 21, 2024: European Journal of Heart Failure